Cargando…
Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
BACKGROUND: The treatment for diabetic macular edema (DME) has revolutionized during the last 15 years after the introduction of intravitreal anti-VEGF agents. The aim of the current study is to evaluate the real-world visual outcomes of diabetic macular edema (DME) treatment in patients with type 1...
Autores principales: | Wirkkala, Joonas, Kubin, Anna-Maria, Ohtonen, Pasi, Yliselä, Joona, Siik, Taru, Hautala, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178825/ https://www.ncbi.nlm.nih.gov/pubmed/35681133 http://dx.doi.org/10.1186/s12886-022-02482-z |
Ejemplares similares
-
Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study
por: Korva-Gurung, Ida, et al.
Publicado: (2023) -
Incidence and prevalence of neovascular age-related macular degeneration: 15-year epidemiological study in a population-based cohort in Finland
por: Korva-Gurung, Ida, et al.
Publicado: (2023) -
Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy
por: Wirkkala, Joonas, et al.
Publicado: (2019) -
Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014) -
Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
por: Distefano, Laura N., et al.
Publicado: (2017)